ReproNovo was founded by a team with expertise in the reproductive medicine space. With years of immersion in this field, we possess deep knowledge of drug development in reproductive medicine, the treatment landscape and needs for both patients and physicians. 

Our team has successfully brought numerous compounds to market. Drawing upon our in-depth experience in designing and executing clinical programs we are strongly committed to bring new treatments to patients in underserved areas in reproductive medicine.  

ReproNovo is headquartered in Lausanne, Switzerland, with its primary development team located in Copenhagen, Denmark. An additional development site will be established in Barcelona, Spain.

Imprint 

ReproNovo S.A. 
Rue de Langallerie 11 
1003 Lausanne, Switzerland

E-Mail: info@repronovo.com

Chief Executive Officer: Jean Duvall
Chief Scientific & Medical Officer: Joan-Carles Arce

Clinical Trials

Fertility

Health Care

Life Sciences

Therapeutics

ReproNovo

ReproNovo's headquarters in Lausanne, Switzerland

This department oversees the planning, execution, and management of clinical projects to ensure adherence to regulatory standards and timelines.

Clinical Project Management

This department is responsible for overall organizational strategy, governance, and executive decision-making.

Executive Leadership

This department oversees and manages clinical research activities to ensure successful trial execution and compliance.

��

People (3)

Jobs (0)

Other teams

Executive Leadership

Clinical Operations

��������

People (3)

Jobs (0)

Other teams

Executive Leadership

Clinical Operations

��